Company Looks to Add Even More Space in the Future to Keep Up with Orders
CHARLES TOWN, W.Va., /PRNewswire/ -- ReBuilder Medical Technologies, Inc. , an emerging medical device manufacturer founded by world-renowned medical device inventor David B. Phillips, Ph.D., today announced it is increasing its manufacturing space to meet growing demand of it cutting edge medical devices and products. The company recently contracted construction of another addition on its facility in Charles Town, WV. It is looking into adding even more space off site for production so it can eliminate any supply and demand issues that may arise in the near future according to Dr. David B. Phillips, President of the Company.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)
“Silver based products alone have added significantly to our sales in 2007 so production facility growth is key to keeping pace with demand,” said Phillips. “In fact, although we have just recently expanded our space, we must seek to add an additional 5,000 square feet of production space to keep up with meeting demands of internet sales alone.”
The company continues to aggressively pursue strategic marketing relationships with catalog companies, physician’s offices, and hospitals to leverage its position in the medical device market. Some of these relationships have been key to the sales growth of ReBuilder according to Phillips. “We are extremely focused in growing sales and building our brand and will continue to do so.”
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc. is a manufacturer of medical devices and innovative technologies founded by world-renowned medical device inventor David B. Phillips, Ph.D. The company’s flagship product is its FDA registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery-powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.
ReBuilder Medical Technologies, Inc. is located in Charles Town, WV. CEO, Dr. David Phillips, Ph.D. is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System, which is used for the early detection of breast cancer, and the AcuPen, a hand-held device that provides the benefits of acupuncture without the use of needles.
More information on ReBuilder Medical Technologies, Inc. and its products can be found at: http://www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
CONTACT: Daena Carter of ReBuilder Medical Technologies, Inc.
+1-304-725-2202
Web site: http://www.rebuildermedical.com/
